Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Bayer AG buy geldnutzer

Bayer AG
Start price
€42.35
23.10.20 / 50%
Target price
€54.00
04.11.21
Performance (%)
17.72%
End price
€49.86
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €49.86. The prediction had a final performance of 17.72%. A total of €2.00 was paid as dividends for this prediction. geldnutzer has 50% into this prediction

Bayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.

Performance without dividends (%)
Name 1w 1m 1y 3y
Bayer AG 2.664% 2.664% -55.184% -50.695%
iShares Core DAX® 1.051% -1.833% 12.822% 15.392%
iShares Nasdaq 100 -0.547% -3.738% 40.625% 42.396%
iShares Nikkei 225® -1.778% -8.115% 16.092% 0.891%
iShares S&P 500 0.002% -2.226% 28.387% 41.095%

According to geldnutzer what are the pros and cons of Bayer AG for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Undervalued
High dividend yield expected
Good rating
Standard Investments for future growth
ROE higher than 10% per year
Capable Management
Good culture
Innovative
Some uniques
Differentiated customer and product portfolio
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Cons
negative Cash Flow expected
Risky balance sheet
Increased challenges to pay loans and raise capital
Growths slower than the competition
Sustainability is not important
high free float
Higher risks for its business

Comments by geldnutzer for this prediction

In the thread Bayer AG diskutieren
Prediction Buy
Perf. (%) 17.72%
Target price 48.000
Change
Ends at 04.11.21

Buy mit Kursziel 48,0

geldnutzer 
1
Report Share
23.10.20
Prediction Buy
Perf. (%) 17.72%
Target price 43.000
Change
Ends at 04.11.21

Kursziel geändert auf 43,0

geldnutzer 
0
Report Share
28.10.20
Prediction Buy
Perf. (%) 17.72%
Target price 46.000
Change
Ends at 04.11.21

Kursziel geändert auf 46,0

geldnutzer 
0
Report Share
04.11.20
Prediction Buy
Perf. (%) 17.72%
Target price 49.000
Change
Ends at 04.11.21

Kursziel geändert auf 49,0

geldnutzer 
0
Report Share
09.11.20
Prediction Buy
Perf. (%) 17.72%
Target price 54.000
Change
Ends at 04.11.21

Kursziel geändert auf 54,0

geldnutzer 
0
Report Share
22.12.20
Prediction Buy
Perf. (%) 17.72%
Target price 59.000
Change
Ends at 04.11.21

Kursziel geändert auf 59,0

geldnutzer 
0
Report Share
08.01.21
Prediction Buy
Perf. (%) 17.72%
Target price 54.000
Change
Ends at 04.11.21

Kursziel geändert auf 54,0

geldnutzer 
0
Report Share
01.11.21
In the thread Trading Bayer AG
Prediction Buy
Perf. (%) 17.72%
Target price 54.000
Change
Ends at 04.11.21

Die von geldnutzer gewählte maximale Laufzeit wurde überschritten

geldnutzer 
0
Report Share
05.11.21